Species comparison of compounds with known blood pressure effects in a vascular smooth muscle cell collagen contraction assay

IF 1.3 4区 医学 Q4 PHARMACOLOGY & PHARMACY Journal of pharmacological and toxicological methods Pub Date : 2023-09-01 DOI:10.1016/j.vascn.2023.107290
Jessica Treadway, Aimee Bielinski , Mark Zafiratos , James Polakowski
{"title":"Species comparison of compounds with known blood pressure effects in a vascular smooth muscle cell collagen contraction assay","authors":"Jessica Treadway,&nbsp;Aimee Bielinski ,&nbsp;Mark Zafiratos ,&nbsp;James Polakowski","doi":"10.1016/j.vascn.2023.107290","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>There is a great need for new approaches early in drug discovery that have the potential to improve clinical translation of compound-mediated cardiovascular effects. Current approaches frequently rely on <em>in vivo</em> animal models or <em>in vitro</em> tissue bath preparations, both of which are low throughput and costly. An <em>in vitro</em> surrogate screen for blood pressure using primary human cells may serve as a higher throughput method to quickly select compounds void of this secondary pharmacology and potentially improve late-stage drug development outcomes.</p></div><div><h3>Methods</h3><p>In this study, we investigated 10 compounds with published <em>in vivo</em> blood pressure effects in a commercially available collagen contraction assay and evaluated rat, human, and canine (aortic) vascular smooth muscle cells (VSMCs). The aim of this study was to evaluate consistency between species and test their ability to predict the effects of known human vasodilators and constrictors. VSMCs were embedded at the same cell density in a collagen matrix which then floated freely in media containing test compounds. Collagen discs contracted faster than vehicle treated controls when incubated with a constrictor, and slower in the presence of a dilator.</p></div><div><h3>Results</h3><p>Rat VSMCs responded as predicted of a VSMC-only culture to 9 out of 10 compounds. Human VSMCs responded as predicted to 8 out of 10 compounds, and canine VSMCs responded to 7 out of 10 compounds.</p></div><div><h3>Discussion</h3><p>Our results suggest that rat VSMCs predict 90% of the effects of known vasoactive compounds in the collagen contraction assay while human and canine VSMCs were slightly less predictive (80% and 70%, respectively). Although blood pressure regulation is a multi-faceted and complex process, our data suggests the collagen smooth muscle contraction assay is useful as a qualitative early screen of compounds that act directly on smooth muscle cells of the arterial vasculature.</p></div>","PeriodicalId":16767,"journal":{"name":"Journal of pharmacological and toxicological methods","volume":"123 ","pages":"Article 107290"},"PeriodicalIF":1.3000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmacological and toxicological methods","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1056871923000412","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

There is a great need for new approaches early in drug discovery that have the potential to improve clinical translation of compound-mediated cardiovascular effects. Current approaches frequently rely on in vivo animal models or in vitro tissue bath preparations, both of which are low throughput and costly. An in vitro surrogate screen for blood pressure using primary human cells may serve as a higher throughput method to quickly select compounds void of this secondary pharmacology and potentially improve late-stage drug development outcomes.

Methods

In this study, we investigated 10 compounds with published in vivo blood pressure effects in a commercially available collagen contraction assay and evaluated rat, human, and canine (aortic) vascular smooth muscle cells (VSMCs). The aim of this study was to evaluate consistency between species and test their ability to predict the effects of known human vasodilators and constrictors. VSMCs were embedded at the same cell density in a collagen matrix which then floated freely in media containing test compounds. Collagen discs contracted faster than vehicle treated controls when incubated with a constrictor, and slower in the presence of a dilator.

Results

Rat VSMCs responded as predicted of a VSMC-only culture to 9 out of 10 compounds. Human VSMCs responded as predicted to 8 out of 10 compounds, and canine VSMCs responded to 7 out of 10 compounds.

Discussion

Our results suggest that rat VSMCs predict 90% of the effects of known vasoactive compounds in the collagen contraction assay while human and canine VSMCs were slightly less predictive (80% and 70%, respectively). Although blood pressure regulation is a multi-faceted and complex process, our data suggests the collagen smooth muscle contraction assay is useful as a qualitative early screen of compounds that act directly on smooth muscle cells of the arterial vasculature.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血管平滑肌细胞胶原收缩测定中具有已知血压作用的化合物的种类比较
引言在药物发现的早期,非常需要有潜力改善化合物介导的心血管作用的临床转化的新方法。目前的方法经常依赖于体内动物模型或体外组织浴制剂,这两者都是低产量和昂贵的。使用原代人类细胞进行血压的体外替代筛选可能是一种更高通量的方法,可以快速选择没有这种二级药理学的化合物,并有可能改善后期药物开发结果。方法在本研究中,我们在市售的胶原收缩试验中研究了10种已发表体内血压作用的化合物,并评估了大鼠、人和犬(主动脉)血管平滑肌细胞(VSMCs)。本研究的目的是评估物种之间的一致性,并测试它们预测已知人类血管舒张剂和收缩剂作用的能力。将VSMCs以相同的细胞密度包埋在胶原基质中,然后胶原基质在含有测试化合物的培养基中自由漂浮。当与收缩剂一起孵育时,胶原盘比载体处理的对照收缩得更快,而在扩张器的存在下收缩得更慢。结果大鼠VSMCs对10种化合物中的9种化合物的反应与仅培养VSMC的预测一致。人VSMCs对10种化合物中的8种有反应,犬VSMCs对7种化合物有反应。讨论我们的结果表明,在胶原收缩测定中,大鼠VSMCs可预测90%的已知血管活性化合物的作用,而人类和犬VSMCs的预测性略低(分别为80%和70%)。尽管血压调节是一个多方面和复杂的过程,但我们的数据表明,胶原蛋白平滑肌收缩试验作为直接作用于动脉血管平滑肌细胞的化合物的定性早期筛选是有用的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of pharmacological and toxicological methods
Journal of pharmacological and toxicological methods PHARMACOLOGY & PHARMACY-TOXICOLOGY
CiteScore
3.60
自引率
10.50%
发文量
56
审稿时长
26 days
期刊介绍: Journal of Pharmacological and Toxicological Methods publishes original articles on current methods of investigation used in pharmacology and toxicology. Pharmacology and toxicology are defined in the broadest sense, referring to actions of drugs and chemicals on all living systems. With its international editorial board and noted contributors, Journal of Pharmacological and Toxicological Methods is the leading journal devoted exclusively to experimental procedures used by pharmacologists and toxicologists.
期刊最新文献
Molecular imaging of excitability difference between alkaloids/salts (nicotine, nicotinic benzoate, caffeine and arecoline hydrobromide) In-situ polyherbal gel as biomedicine in the management of Alzheimer's disease: Understanding ameliorative potential in Trimethyltin induced neurodegeneration Evaluation of 4 quantification methods for monitoring 16 antidepressant drugs and their metabolites in human plasma by LC-MS/MS Comparative toxicity assessment of selected nanoparticles using different experimental model organisms Evaluating the proarrhythmic risk of delayed-action compounds in serum free cell culture conditions; serum-starvation accelerates/amplifies the effect of probucol on the KCNQ1 + KCNE1 channel
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1